s-nitrosocaptopril has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, HY; Jia, L; Li, YM; Lin, M; Xie, HZ | 1 |
1 other study(ies) available for s-nitrosocaptopril and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Why do we lack a specific magic anti-COVID-19 drug? Analyses and solutions.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Captopril; Cardiovascular System; COVID-19; COVID-19 Drug Treatment; Drug Development; Drug Repositioning; Humans; Nebulizers and Vaporizers; Pharmaceutical Preparations; Respiratory System; SARS-CoV-2; Treatment Outcome | 2021 |